Inventor · disambiguated record
Mark Shearman
Also filed as: SHEARMAN MARK · SHEARMAN MARK S · SHEARMAN MARK STEVEN
4 granted patents·11 pending applications·24 citations·filing 2001–2025
71Inventor score
Files withAPPLIED GENETIC TECH CORPORATION4LEWIS HUW DAVID3LILLY CO ELI3MERCK SHARP & DOHME2BEACON THERAPEUTICS LTD1
Top patents by PatentIndex Score
15 records- 0182US8362075B2Cyclohexyl sulphones for treatment of cancerMERCK SHARP & DOHME·Filed 2006·Granted Jan 29, 2013·9 cites·12 claims
- 0282US8242103B2Sulphamides for treatment of cancerLEWIS HUW DAVID·Filed 2006·Granted Aug 14, 2012·9 cites·15 claims
- 0370US7365196B2Sulphonamido-substituted bridged bicycloalkyl derivativesMERCK SHARP & DOHME·Filed 2001·Granted Apr 29, 2008·6 cites·10 claims
- 0464US2024318199A1Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disordersBEACON THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0557US12241077B2Adeno-associated virus (AAV) systems for treatment of genetic hearing lossLILLY CO ELI·Filed 2020·Granted Mar 4, 2025·0 cites·18 claims
- 0656US2024226330A9Variant adeno-associated virus (aav) capsid polypeptides and gene therapeutics thereof for treatment of hearing lossLILLY CO ELI·Filed 2023·Application pending·0 cites
- 0755US2024067984A1Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2023·Application pending·0 cites
- 0851US2025236887A1Adeno-associated virus (aav) systems for treatment of genetic hearing lossLILLY CO ELI·Filed 2025·Application pending·0 cites
- 0950US2021147872A1Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1046US2009306058A1Sulphone Derivatives for Treatment of CancerLEWIS HUW DAVID·Filed 2006·Application pending·0 cites
- 1146US2006241133A1Electrically variable pneumatic structural elementSHEARMAN MARK S·Filed 2004·Application pending·0 cites
- 1244US2021147873A1Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1341US2021123076A1Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1436US2009215775A1Sulphonamido-Substituted Cyclohexyl Sulphones for Treatment of CancerLEWIS HUW DAVID·Filed 2006·Application pending·0 cites
- 1531US2008274476A1Assay MethodBEHER DIRK·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Shearman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →